Empty Capsules Market by Type (Gelatin Capsules, Non-Gelatin Capsules), by Application (Pharmaceutical, Nutraceutical), by End-Use Industry (Drug Manufacturers, Dietary Supplement Manufacturers, Contract Manufacturers); Global Trends and Forecast (2024 – 2030)

As per Intent Market Research, the Empty Capsules Market was valued at USD 3.8 billion in 2023 and will surpass USD 6.8 billion by 2030; growing at a CAGR of 8.7% during 2024 - 2030.

vv The empty capsules market plays a crucial role in the pharmaceutical and nutraceutical industries, facilitating the delivery of active ingredients in a convenient, stable, and efficient form. Empty capsules are used for encapsulating powdered, granular, or liquid formulations, providing an ideal medium for oral administration. As the demand for capsules continues to rise due to the growth in the pharmaceutical and dietary supplement sectors, manufacturers are focusing on innovations that enhance product functionality and consumer safety. The market is also experiencing a shift toward more sustainable and health-conscious options, such as non-gelatin capsules, in response to growing consumer preferences for plant-based alternatives.

Gelatin Capsules Are Largest Product Type Owing to Wide Acceptance in the Pharmaceutical Industry

Gelatin capsules continue to be the largest product type in the empty capsules market due to their long-standing use and widespread acceptance, particularly in the pharmaceutical industry. Gelatin, a protein derived from animal collagen, provides an excellent medium for encapsulating both solid and liquid substances. These capsules are highly valued for their efficient dissolution in the stomach, fast absorption, and high compatibility with a broad range of active pharmaceutical ingredients (APIs).

Despite the increasing demand for non-gelatin capsules, gelatin capsules remain dominant due to their proven reliability, cost-effectiveness, and well-established manufacturing processes. The extensive use of gelatin capsules in both prescription and over-the-counter medications contributes to their leading position in the market. The pharmaceutical industry's reliance on gelatin capsules for delivering APIs in a stable, precise, and controlled manner ensures their continued prevalence in the empty capsules market.

Pharmaceutical Application Is Largest Due to Expanding Drug Production

The pharmaceutical application segment holds the largest share of the empty capsules market, driven by the expanding production and consumption of pharmaceutical drugs. Capsules are widely used in the pharmaceutical industry for delivering medications in a user-friendly form, offering benefits such as ease of ingestion, accurate dosing, and effective release of active ingredients. Capsules are also preferred for encapsulating a wide variety of formulations, including powders, pellets, and liquids.

The pharmaceutical industry's growth, particularly the increasing demand for oral dosage forms due to their convenience and patient compliance, significantly boosts the demand for empty capsules. Additionally, the trend toward personalized medicine and the growing prevalence of chronic diseases that require long-term medication further strengthens the pharmaceutical sector's demand for encapsulation solutions. As the pharmaceutical industry expands globally, the need for versatile and efficient capsule solutions continues to grow.

Drug Manufacturers Are Largest End-Use Industry Owing to High Demand for Pharmaceutical Products

Drug manufacturers constitute the largest end-use industry for empty capsules, driven by the ongoing growth in global drug production. As pharmaceutical companies continue to expand their product offerings and develop new treatments for a wide range of conditions, the demand for capsules to deliver these therapies remains high. Capsules are particularly suited for drug formulations that require controlled release, precise dosages, or protection from degradation due to environmental factors like light and moisture.

The increasing emphasis on innovation within the drug manufacturing industry, including the development of novel drug delivery systems and specialized capsule formulations, is further driving the demand for empty capsules. With ongoing advancements in drug formulations, such as extended-release and enteric-coated drugs, drug manufacturers are investing heavily in capsule technology to meet these evolving needs. The growing pharmaceutical manufacturing sector is, therefore, a key driver of market growth for empty capsules.

North America Is Largest Region Owing to Strong Pharmaceutical Manufacturing Base

North America is the largest region in the empty capsules market, primarily due to its well-established pharmaceutical manufacturing base and high demand for pharmaceutical products. The United States, in particular, stands as a global leader in pharmaceutical production, with an increasing focus on generic drug manufacturing and the development of new therapies. This has spurred the demand for empty capsules, as pharmaceutical companies seek reliable and efficient means of delivering oral medications.

Additionally, North America benefits from a strong regulatory framework and advanced technological infrastructure that supports the production of high-quality capsules. The region's growing aging population, which leads to a higher incidence of chronic diseases and related medication needs, also contributes to the continued demand for capsules in the pharmaceutical industry. As North America remains at the forefront of pharmaceutical innovation, it is expected to maintain its dominant position in the empty capsules market.

Competitive Landscape and Leading Companies

The empty capsules market is competitive, with major players such as Capsugel (Lonza), ACG Associated Capsules, Qualicaps, and Suheung Co. Ltd. leading the industry. These companies focus on expanding their product portfolios, enhancing manufacturing capabilities, and innovating in capsule formulations to meet the diverse needs of the pharmaceutical and nutraceutical sectors. Key players are increasingly investing in research and development to introduce new types of capsules, such as vegetarian, vegan, and other plant-based capsules, in response to the growing consumer demand for alternatives to traditional gelatin capsules.

The market is also witnessing an increasing trend of mergers and acquisitions, with leading companies seeking to expand their regional presence and enhance their product offerings. As companies focus on improving manufacturing processes, increasing capacity, and ensuring product quality, the competitive landscape remains dynamic. To maintain a competitive edge, leading players are also exploring sustainable packaging solutions and environmentally friendly production techniques, ensuring that they meet both consumer and regulatory demands. As the demand for high-quality, innovative, and sustainable capsules grows, the competitive landscape will continue to evolve.

Recent Developments:

• Lonza Group (Capsugel) launched a new range of plant-based capsules for the growing demand in vegetarian and vegan formulations.
• Qualicaps announced the development of a new gelatin-free capsule aimed at expanding its market share in the nutraceutical sector.
• ACG Worldwide introduced a new line of hard gelatin capsules designed to improve stability and enhance product shelf life.
• Medi-Caps Ltd. expanded its production capacity to meet the growing demand for capsules in the pharmaceutical industry.
• Natural Capsules Limited received regulatory approval for its new vegetarian capsule product line aimed at the expanding global demand for plant-based supplements.

List of Leading Companies:

• Capsugel (Lonza Group)
• Qualicaps
• ACG Worldwide
• Suheung Co., Ltd.
• Gelita AG
• Natural Capsules Limited
• Medi-Caps Ltd.
• Shijiazhuang N normative Co., Ltd.
• Shaoxing Kangke Capsule Co., Ltd.
• EuroCaps Ltd.
• Vcaps (Capsugel)
• JRS Pharma
• Ningbo Zhenhai Fuchang Capsule Co., Ltd.
• Fuji Capsule Co., Ltd.
• Healthcaps India Ltd.

Report Scope: